Modus Therapeutics raises SEK 7.6 million in directed share placement

PUBT · 1d ago
Modus Therapeutics raises SEK 7.6 million in directed share placement
  • Modus Therapeutics priced a directed share issue of 20,000,000 shares at SEK 0.38, raising SEK 7.6 million gross.
  • Placement investors included Tellus Equity AB, Selandia Alpha Invest A/S, and two existing minor shareholders; all shares subscribed.
  • Proceeds earmarked for 2027 development, including product manufacturing for future programs, including severe malaria collaboration.
  • Funds also intended to extend runway for business development ahead of Phase IIa CKD-with-anemia proof-of-concept data around 2026/2027.
  • Issue lifts shares outstanding to 168,701,791 from 148,701,791, implying about 11.9% dilution.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Modus Therapeutics Holding AB published the original content used to generate this news brief on September 03, 2026, and is solely responsible for the information contained therein.